Pfizer, Apotex End Patent Fight Over Generic Lipitor
U.S. District Judge Edmond E. Chang approved a joint motion to dismiss without prejudice claims and counterclaims over Apotex’s abbreviated new drug application for generic Lipitor. Terms of the settlement agreement were not disclosed.
New York-based Pfizer lodged complaints in Illinois and Delaware alleging patent infringement in December 2008, in response to...
To view the full article, register now.